Shopping Cart 0
Cart Subtotal
USD 0

Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Heidelberg Pharma AG (WL6)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma's pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors. Through its subsidiaries it also provides preclinical contract research services and an antibody drug conjugate (ADC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.

Heidelberg Pharma AG Key Recent Developments

Jul 12,2018: Heidelberg Pharma reports on first half -year

Apr 12,2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018

Apr 09,2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences

Mar 22,2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update

Jan 08,2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Heidelberg Pharma AG-Key Facts 5

Heidelberg Pharma AG-Key Employees 6

Heidelberg Pharma AG-Key Employee Biographies 7

Heidelberg Pharma AG-Major Products and Services 8

Heidelberg Pharma AG-History 9

Heidelberg Pharma AG-Company Statement 12

Heidelberg Pharma AG-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Heidelberg Pharma AG-Business Description 16

Heidelberg Pharma AG-Corporate Strategy 17

Heidelberg Pharma AG-SWOT Analysis 18

SWOT Analysis-Overview 18

Heidelberg Pharma AG-Strengths 18

Heidelberg Pharma AG-Weaknesses 19

Heidelberg Pharma AG-Opportunities 20

Heidelberg Pharma AG-Threats 21

Heidelberg Pharma AG-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Heidelberg Pharma AG, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Jul 12, 2018: Heidelberg Pharma reports on first half -year 32

Apr 12, 2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018 34

Apr 09, 2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences 36

Mar 22, 2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update 37

Jan 08, 2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program 40

Jul 13, 2017: WILEX reports on first half-year 41

Apr 12, 2017: WILEX: Interim management statement on the first three months of 2017 43

Mar 30, 2017: WILEX announces financial figures for the 2016 fiscal year and reports on course of business 45

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

Heidelberg Pharma AG, Performance Chart (2013-2017) 26

Heidelberg Pharma AG, Ratio Charts 28

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Heidelberg Pharma AG, Key Facts 5

Heidelberg Pharma AG, Key Employees 6

Heidelberg Pharma AG, Key Employee Biographies 7

Heidelberg Pharma AG, Major Products and Services 8

Heidelberg Pharma AG, History 9

Heidelberg Pharma AG, Subsidiaries 14

Heidelberg Pharma AG, Key Competitors 22

Heidelberg Pharma AG, Ratios based on current share price 23

Heidelberg Pharma AG, Annual Ratios 24

Heidelberg Pharma AG, Annual Ratios (Cont...1) 25

Heidelberg Pharma AG, Interim Ratios 27

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Heidelberg Pharma AG, Recent Deals Summary 31

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Heidelberg Pharma AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

U3 Pharma AG

Navigo Proteins GmbH

Merck KGaA

MediGene AG

Epigenomics AG

Biotest AG

Baxter Oncology GmbH

4SC AG